131
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Ketamine: Miracle Drug or Latest Fad?

, &
Pages 217-221 | Received 20 Mar 2017, Accepted 13 Apr 2017, Published online: 01 Aug 2017

References

  • Domino EF . Taming the ketamine tiger. 1965 . Anesthesiology113 ( 3 ), 678 – 684 ( 2010 ).
  • Woolf CJ , ThompsonSW . The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states . Pain44 ( 3 ), 293 – 299 ( 1991 ).
  • Maher DP , ChenL , MaoJ . Intravenous ketamine infusions for neuropathic pain management: a promising therapy in need of optimization . Anesth. Analg.124 ( 2 ), 661 – 674 ( 2017 ).
  • Noppers I , NiestersM , SwartjesMet al. Absence of long-term analgesic effect from a short-term s-ketamine infusion on fibromyalgia pain: a randomized, prospective, double blind, active placebo-controlled trial . Eur. J. Pain15 ( 9 ), 942 – 949 ( 2011 ).
  • Patil S , AnitescuM . Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis . Pain Med.13 ( 2 ), 263 – 269 ( 2012 ).
  • Eide PK , JorumE , StubhaugA , BremnesJ , BreivikH . Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo . Pain58 ( 3 ), 347 – 354 ( 1994 ).
  • Schwartzman RJ , AlexanderGM , GrothusenJR , PaylorT , ReichenbergerE , PerreaultM . Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study . Pain147 ( 1–3 ), 107 – 115 ( 2009 ).
  • Sigtermans MJ , Van HiltenJJ , BauerMCet al. Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1 . Pain145 ( 3 ), 304 – 311 ( 2009 ).
  • Amr YM . Multi-day low dose ketamine infusion as adjuvant to oral gabapentin in spinal cord injury related chronic pain: a prospective, randomized, double blind trial . Pain Physician13 ( 3 ), 245 – 249 ( 2010 ).
  • Hocking G , CousinsMJ . Ketamine in chronic pain management: an evidence-based review . Anesth. Analg.97 ( 6 ), 1730 – 1739 ( 2003 ).
  • Himmelseher S , DurieuxME . Ketamine for perioperative pain management . Anesthesiology102 ( 1 ), 211 – 220 ( 2005 ).
  • Kvarnstrom A , KarlstenR , QuidingH , GordhT . The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury . Acta Anaesthesiol. Scand.48 ( 4 ), 498 – 506 ( 2004 ).
  • Dworkin RH , TurkDC , WyrwichKWet al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations . J. Pain9 ( 2 ), 105 – 121 ( 2008 ).
  • Dillon P , CopelandJ , JansenK . Patterns of use and harms associated with non-medical ketamine use . Drug Alcohol Depend.69 ( 1 ), 23 – 28 ( 2003 ).
  • McCloud TL , CaddyC , JochimJet al. Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults . Cochrane Database Syst. Rev. ( 9 ), doi: 10.1002/14651858.CD011611.pub2Cd011611 CD011611 ( 2015 ).
  • Schwartzman RJ , GrothusenJ , KieferTR , RohrP . Neuropathic central pain: epidemiology, etiology, and treatment options . Arch. Neurol.58 ( 10 ), 1547 – 1550 ( 2001 ).
  • Zhou QQ , ImbeH , ZouS , DubnerR , RenK . Selective upregulation of the flip-flop splice variants of AMPA receptor subunits in the rat spinal cord after hindpaw inflammation . Brain Res. Mol. Brain Res.88 ( 1–2 ), 186 – 193 ( 2001 ).
  • Niesters M , Khalili-MahaniN , MartiniCet al. Effect of subanesthetic ketamine on intrinsic functional brain connectivity: a placebo-controlled functional magnetic resonance imaging study in healthy male volunteers . Anesthesiology117 ( 4 ), 868 – 877 ( 2012 ).
  • Eide PK , StubhaugA , StenehjemAE . Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation . Neurosurgery37 ( 6 ), 1080 – 1087 ( 1995 ).
  • Kvarnstrom A , KarlstenR , QuidingH , EmanuelssonBM , GordhT . The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain . Acta Anaesthesiol. Scand.47 ( 7 ), 868 – 877 ( 2003 ).
  • Niesters M , AartsL , SartonE , DahanA . Influence of ketamine and morphine on descending pain modulation in chronic pain patients: a randomized placebo-controlled cross-over proof-of-concept study . Br. J. Anaesth.110 ( 6 ), 1010 – 1016 ( 2013 ).
  • Wood L , EggerM , GluudLLet al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study . BMJ336 ( 7644 ), 601 – 605 ( 2008 ).
  • Savovic J , JonesHE , AltmanDGet al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials . Ann. Intern. Med.157 ( 6 ), 429 – 438 ( 2012 ).
  • Hrobjartsson A , ThomsenAS , EmanuelssonFet al. Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors . BMJ344 , e1119 ( 2012 ).
  • Mercadante S , ArcuriE , TirelliW , CasuccioA . Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study . J. Pain Symptom Manage.20 ( 4 ), 246 – 252 ( 2000 ).
  • Pickering AE , MccabeCS . Prolonged ketamine infusion as a therapy for complex regional pain syndrome: synergism with antagonism?Br. J. Clin. Pharmacol.77 ( 2 ), 233 – 238 ( 2014 ).
  • Carr DB , GoudasLC , DenmanWTet al. Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study . Pain108 ( 1–2 ), 17 – 27 ( 2004 ).
  • Soto E , StewartDR , MannesAJet al. Oral ketamine in the palliative care setting: a review of the literature and case report of a patient with neurofibromatosis type 1 and glomus tumor-associated complex regional pain syndrome . Am J. Hosp. Palliat29 ( 4 ), 308 – 317 ( 2012 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.